Page 106 - Read Online

Xu et al. J Transl Genet Genom 2021;5:218-39 https://dx.doi.org/10.20517/jtgg.2021.20 Page 236

DOI PubMed PMC
100. Young RP, Hopkins RJ. A review of the Hispanic paradox: time to spill the beans? Eur Respir Rev 2014;23:439-49. DOI PubMed
101. Franzini L, Ribble JC, Keddie AM. Understanding the Hispanic paradox. Ethn Dis 2011;11:496-518. PubMed
102. Swan J, Edwards BK. Cancer rates among American Indians and Alaska Natives: is there a national perspective. Cancer
2003;98:1262-72. DOI PubMed
103. Nathan PC, Wasilewski-Masker K, Janzen LA. Long-term outcomes in survivors of childhood acute lymphoblastic leukemia.
Hematol Oncol Clin North Am 2009;23:1065-82, vi. DOI PubMed
104. Essig S, Li Q, Chen Y, et al. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic
leukaemia: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 2014;15:841-51. DOI PubMed PMC
105. Gofman I, Ducore J. Risk factors for the development of obesity in children surviving ALL and NHL. J Pediatr Hematol Oncol
2009;31:101-7. DOI PubMed
106. Sadighi ZS, Ness KK, Hudson MM, et al. Headache types, related morbidity, and quality of life in survivors of childhood acute
lymphoblastic leukemia: a prospective cross sectional study. Eur J Paediatr Neurol 2014;18:722-9. DOI PubMed PMC
107. Shoag JM, Barredo JC, Lossos IS, Pinheiro PS. Acute lymphoblastic leukemia mortality in Hispanic Americans. Leuk Lymphoma
2020;61:2674-81. DOI PubMed
108. Eche IJ, Aronowitz T. A literature review of racial disparities in overall survival of black children with acute lymphoblastic leukemia
compared with white children with acute lymphoblastic leukemia. J Pediatr Oncol Nurs 2020;37:180-94. DOI PubMed
109. Bryant C, Mayhew M, Fleites J, Lozano J, Saunders JM. Comparison of five-year survival rate between black and white children with
acute lymphoblastic leukemia. Cureus 2020;12:e11797. DOI PubMed PMC
110. Siegel SE, Stock W, Johnson RH, et al. Pediatric-inspired treatment regimens for adolescents and young adults with philadelphia
chromosome-negative acute lymphoblastic leukemia: a review. JAMA Oncol 2018;4:725-34. DOI PubMed PMC
111. National Cancer Institute. Cancer Stat Facts: leukemia - acute lymphocytic leukemia (ALL). Available from:
https://seer.cancer.gov/statfacts/html/alyl.html. [Last accessed on 15 Jun 2021].
112. Burmeister T, Schwartz S, Bartram CR, Gökbuget N, Hoelzer D, Thiel E; GMALL study group. Patients' age and BCR-ABL
frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group. Blood 2008;112:918-9. DOI PubMed
113. Byun JM, Koh Y, Shin DY, et al; Korean Adult ALL Working Party; Korean Society of Hematology. BCR-ABL translocation as a
favorable prognostic factor in elderly patients with acute lymphoblastic leukemia in the era of potent tyrosine kinase inhibitors.
Haematologica 2017;102:e187-90. DOI PubMed PMC
114. Moorman AV, Chilton L, Wilkinson J, Ensor HM, Bown N, Proctor SJ. A population-based cytogenetic study of adults with acute
lymphoblastic leukemia. Blood 2010;115:206-14. DOI PubMed
115. Paulsson K, Lilljebjörn H, Biloglav A, et al. The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia.
Nat Genet 2015;47:672-6. DOI PubMed
116. Geyer MB, Hsu M, Devlin SM, Tallman MS, Douer D, Park JH. Overall survival among older US adults with ALL remains low
despite modest improvement since 1980: SEER analysis. Blood 2017;129:1878-81. DOI PubMed PMC
117. Bassan R, Bourquin JP, DeAngelo DJ, Chiaretti S. New approaches to the management of adult acute lymphoblastic leukemia. J Clin
Oncol 2018:JCO2017773648. DOI PubMed
118. Wenzinger C, Williams E, Gru AA. Updates in the pathology of precursor lymphoid neoplasms in the revised fourth edition of the
WHO classification of tumors of hematopoietic and lymphoid tissues. Curr Hematol Malig Rep 2018;13:275-88. DOI PubMed
119. Iacobucci I, Mullighan CG. Genetic basis of acute lymphoblastic leukemia. J Clin Oncol 2017;35:975-83. DOI PubMed PMC
120. You MJ, Medeiros LJ, Hsi ED. T-lymphoblastic leukemia/lymphoma. Am J Clin Pathol 2015;144:411-22. DOI PubMed
121. Rowe JM, Buck G, Burnett AK, et al; ECOG; MRC/NCRI Adult Leukemia Working Party. Induction therapy for adults with acute
lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood
2005;106:3760-7. DOI PubMed
122. Marks DI, Paietta EM, Moorman AV, et al. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype,
cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). Blood 2009;114:5136-45. DOI
PubMed PMC
123. Papaemmanuil E, Rapado I, Li Y, et al. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in
ETV6-RUNX1 acute lymphoblastic leukemia. Nat Genet 2014;46:116-25. DOI PubMed PMC
124. Bhojwani D, Pei D, Sandlund JT, et al. ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with
contemporary therapy. Leukemia 2012;26:265-70. DOI PubMed PMC
125. Chokkalingam AP, Hsu LI, Metayer C, et al. Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in
Hispanics. Cancer Causes Control 2013;24:1789-95. DOI PubMed PMC
126. Aldrich MC, Zhang L, Wiemels JL, et al. Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in
California. Cancer Epidemiol Biomarkers Prev 2006;15:578-81. DOI PubMed
127. Kurzrock R, Kantarjian HM, Druker BJ, Talpaz M. Philadelphia chromosome-positive leukemias: from basic mechanisms to
molecular therapeutics. Ann Intern Med 2003;138:819-30. DOI PubMed
128. Igwe IJ, Yang D, Merchant A, et al. The presence of Philadelphia chromosome does not confer poor prognosis in adult pre-B acute
lymphoblastic leukaemia in the tyrosine kinase inhibitor era - a surveillance, epidemiology, and end results database analysis. Br J
Haematol 2017;179:618-26. DOI PubMed PMC
129. Uckun FM, Nachman JB, Sather HN, et al. Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic
leukemia in the context of contemporary intensive therapies: a report from the Children’s Cancer Group. Cancer 1998;83:2030-9.